Skip to main content

Table 1 Clinicopathologic characteristics of patients with advanced metastatic RCC treated with any kind of nephrectomy and no nephrectomy

From: C-reactive protein in patients with advanced metastatic renal cell carcinoma: Usefulness in identifying patients most likely to benefit from initial nephrectomy

Characteristic

Any nephrectomy

No nephrectomy

P

Number of patients (%)

129 (71.3)

52 (28.7)

 

Age, yr

   

Median

62

67.5

0.006*

Range

30–81

36–86

 

Sex

   

Female

33

15

0.780**

Male

96

37

 

PS

   

0

64

14

<0.001*

1

57

20

 

≥2

8

18

 

No. of metastatic organ sites

0(T4N0M0)

6

1

0.295*

1

82

22

 

2

17

6

 

≥3

24

23

 

Metastatic area

   

Lung

68

30

0.657**

Bone

46

13

0.227**

Lymph node

31

19

0.089**

Liver

4

7

0.008**

CNS

4

4

0.174**

Others

17

7

0.856*

Median

8.00

9.25

0.008*

Range

2.50–

24.0

 

Histopathology

   

Clear cell

109

17

 

Papillary

4

0

 

Chromophobe

1

0

 

Collecting-duct

4

0

 

Sarcomatoid change

3

5

 

Others or not determined

8

30

 

Tumor grading (Fuhrman)

  

0.205*

G1

4

1

 

G2

43

4

 

G3

57

7

 

G4

20

6

 

X

 

5

34

  1. *Mann-Whitney U test; **Chi-square test.